Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: Preliminary results and survival analysis

Surgical Oncology 2015 January 8 [Epub ahead of print] [Link] Hubert J, Thiboutot E, Dubé P, Cloutier AS, Drolet P, Sideris L. Abstract Background Peritoneal mesothelioma is a rare disease with poor prognosis. The present study reports single center experience with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy with oxaliplatin (HIPEC-OX) over an eight-year period.…

Read More

Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications

Bulletin du Cancer. 2008 Jan 30;95(1):141-145. [Link] Eveno C, Dagois S, Guillot E, Gornet JM, Pocard M. Département médicochirurgical de pathologie digestive, Hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris. Abstract Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) is now an entire part of treatment of peritoneal dissemination of colorectal malignancy, and it’s possible to hope prolonged survival.…

Read More